THE EFFECT OF THE AMERICAN HEART ASSOCIATION STEP ONE DIET ON HYPERLIPIDEMIA FOLLOWING RENAL-TRANSPLANTATION

被引:53
作者
MOORE, RA
CALLAHAN, MF
CODY, M
ADAMS, PL
LITCHFORD, M
BUCKNER, K
GALLOWAY, J
机构
[1] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, WINSTON SALEM, NC 27103 USA
[2] UNIV N CAROLINA, GREENSBORO, NC 27412 USA
关键词
D O I
10.1097/00007890-199001000-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cardiovascular disease is a frequent cause of morbidity and mortality following renal transplantation. The percentage of deaths due to ischemic cardiovascular disease and cerebrovascular accidents nearly equals that caused by infection among patients receiving their first transplant, according to data from the European Dialysis and Transplant Association Registry (2). Hypercholesterolemia is a risk factor for cardiovascular disease frequently identified following renal transplantation, and diets low in fat and cholesterol have been suggested as treatment (2,3).Previous studies have not reported the response of LDL cholesterol to dietary treatment, and it is this form of cholesterol that is most closely related to cardiovascular disease (4, 5).The American Heart Association has provided nutritionists with guidelines for the treatment of hyperlipidemic patients which include the Step One Diet (4).Previous dietary studies of renal transplant recipients have allowed a slightly higher intake of fat than that currently recommended by the AHA (2,3).We wondered if an easily reproducible diet well known to nutritionists such as the AHA Step One Diet would be effective in lowering cholesterol levels in hyperlipidemic renal transplant recipients. The purpose of our study was not to define the mechanisms of posttransplant hyperlipidemia, but rather to assess the effectiveness of dietary intervention on hyperlipidemia following renal transplantation. © 1990 by Williams and Wilkins.
引用
收藏
页码:60 / 62
页数:3
相关论文
共 17 条
  • [1] Bazzarre T L, 1983, Nutr Cancer, V5, P201, DOI 10.1080/01635588309513797
  • [2] BEAUMONT JE, 1975, LANCET, V1, P599
  • [3] CATTRAN DC, 1979, ANN INTERN MED, V91, P554, DOI 10.7326/0003-4819-91-4-554
  • [4] CHAN MK, 1981, CLIN NEPHROL, V15, P309
  • [5] CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
  • [6] LIPOPROTEIN LIPID ABNORMALITIES IN HEALTHY RENAL-TRANSPLANT RECIPIENTS - PERSISTENCE OF LOW HDL2 CHOLESTEROL
    ETTINGER, WH
    BENDER, WL
    GOLDBERG, AP
    HAZZARD, WR
    [J]. NEPHRON, 1987, 47 (01): : 17 - 21
  • [7] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [8] GOKAL R, 1979, Q J MED, V48, P507
  • [9] RISK-FACTORS FOR ACCELERATED ATHEROSCLEROSIS IN RENAL-TRANSPLANT RECIPIENTS
    KASISKE, BL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 84 (06) : 985 - 992
  • [10] PERSISTENT HYPERLIPIDEMIA IN RENAL-TRANSPLANT PATIENTS
    KASISKE, BL
    UMEN, AJ
    [J]. MEDICINE, 1987, 66 (04) : 309 - 316